TickerFactsScreenerDevelopers

Theravance Biopharma, Inc. (TBPH) — Revenue

Annual figures by fiscal year, from SEC filings.

2016: $48.65M2017: $15.39M2018: $60.37M2019: $73.41M2020: $71.86M2021: $55.31M2022: $51.35M2023: $57.42M2024: $64.38M2025: $107.46M$107.46M
2016Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$107.46M+66.9%
2024$64.38M+12.1%
2023$57.42M+11.8%
2022$51.35M-7.2%
2021$55.31M-23.0%
2020$71.86M-2.1%
2019$73.41M+21.6%
2018$60.37M+292.4%
2017$15.39M-68.4%
2016$48.65M—